North Star Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
North Star Investment Management's IHE Position: Q1 2026 in Review
North Star Investment Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 11 shares worth $940. The position accounts for ﹤0.01% of the portfolio, ranked #1497.
North Star Investment Management first reported a position in IHE in Q2 2015 and has held it in 26 quarters since. The position peaked at $17K in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- North Star Investment Management held 11 shares of iShares US Pharmaceuticals ETF worth $940 as of Q1 2026.
- North Star Investment Management left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1497 holding.
- North Star Investment Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and has held it in 26 quarters since.
- North Star Investment Management's iShares US Pharmaceuticals ETF position peaked at $17K in Q2 2015.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.